Marye Anne Fox serves as Executive at PHARMACEUTICAL PRODUCT DEVELOPMENT INC, where they oversee executive responsibilities. Since joining the company, Marye Anne Fox has executed 51 insider transactions totaling $6.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 3, 2006 involved receiving (via award) 1,032 shares valued at $0.
Marye Anne Fox currently holds 54,728 shares of PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marye Anne Fox has been a net seller of PPDI stock. They have purchased $97.3K and sold $6.1M worth of shares.
Marye Anne Fox's most recent insider trade was on Jan 3, 2006, when they sold 1,032 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted